AI assistant
Sending…
AVADEL PHARMACEUTICALS PLC — Director's Dealing 2022
Feb 16, 2022
31920_dirs_2022-02-16_38ec0799-6e63-48e7-af6e-3083b3b1d43f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2022-02-14
Reporting Person: Williamson Douglas J (Chief Medical Officer)
More from AVADEL PHARMACEUTICALS PLC
Regulatory Filings
2026
Feb 23
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 12
Director's Dealing
2026
Feb 12
Director's Dealing
2026
Feb 12
Director's Dealing
2026
Feb 12
Delisting Announcement
2026
Feb 12
Director's Dealing
2026
Feb 12
Director's Dealing
2026
Feb 12
Director's Dealing
2026
Feb 12